+987.9%
MRNA vs IBN
+4.2%
+983.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IBN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.8% | +9.4% | +11.5% |
| 7D | +20.6% | +8.9% | +11.7% | +16.9% |
| 30D | +27.1% | +12.6% | +14.5% | +20.6% |
| 3M | +353.4% | +3.1% | +350.3% | +350.8% |
| 6M | +446.3% | +20.6% | +425.7% | +392.9% |
| YTD | +776.2% | +5.8% | +770.4% | +702.1% |
| 1Y | +987.9% | +3.7% | +984.3% | +905.4% |
| All | +987.9% | +4.2% | +983.7% | +905.4% |
Cumulative growth
Daily Returns
Daily percentage return beside IBN.
Daily Out/Under-Performance
Portfolio return minus IBN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IBN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IBN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling